Gossamer Bio's total assets for Q3 2024 were $350.88M, a decrease of -6.04% from the previous quarter. GOSS total liabilities were $296.74M for the fiscal quarter, a 1.65% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.